GI Endoscopy · 3 min read

GLP-1 Agonists, NPO Status, and Aspiration Risk Before Endoscopy in 2026

A 24-hour clear-liquid day is the most consistent safety move. Holding a weekly dose helps EGD-only lists. Do not delay needed urgent endoscopy.

P26-09-20" data-astro-cid-gjtny2mx>Last reviewed September 20, 2026

GLP-1 Agonists, NPO Status, and Aspiration Risk Before Endoscopy in 2026

Clinical Bottom Line

Situation2026 practical answer
Asymptomatic patient, standard fast onlyAGA rapid CPU: you may proceed. Residual gastric contents are still more common on GLP-1s. A 24-hour clear-liquid day is safer than a standard 8-hour solid fast.
Elective EGD on a weekly GLP-1ASGE 2025 suggests holding the weekly dose 7 days, or the daily dose 24 hours, plus 24-hour liquids. The 2026 OCULUS RCT found more clinically significant residual volume when the dose was continued, especially for EGD-only.
EGD plus colonoscopy after a full-day liquid prepResidual contents drop sharply. Same-day colo is the best available mitigation if the drug was not held.
Nausea, vomiting, distention, or known gastroparesisDo not treat this as a routine NPO. Consider delay, gastric ultrasound if you use it, or anesthesia with full-stomach precautions.
Urgent or emergent endoscopyDo not delay needed endoscopy to complete a GLP-1 hold. Use aspiration precautions.

The actual risk is a full stomach, not a pneumonia stampede

GLP-1 and dual GIP/GLP-1 agonists slow gastric emptying. Meta-analyses show more residual gastric contents and more aborted EGDs. They have not shown a clear increase in aspiration pneumonia. That distinction matters. You cancel or intubate for a stomach full of solids. You do not need a myth about epidemic Mendelson syndrome to take the residue seriously.

Standard ASA fasting still applies. It is not enough by itself on a GLP-1

IntakeUsual ASA minimumOn a GLP-1
Clear liquids2 hoursKeep. Encourage clears. Do not revert to NPO after midnight.
Light meal6 hoursPrefer a full clear-liquid day before elective endoscopy.
Heavy or fatty meal8 hoursNot an acceptable last meal the evening before an EGD on a GLP-1.

Gastroparesis, achalasia, and gastric outlet obstruction still need a longer liquid run-in, GLP-1 or not.

Holds vs diet: the societies do not fully agree

Three documents are in active use, and they do not say the same thing:

  • AGA rapid clinical practice update (2023/2024): If the patient followed a standard fast and has no nausea, vomiting, dyspepsia, or distention, proceed. A liquid day may be better than stopping the drug. Holding one weight-loss dose is optional, not mandatory.
  • ASGE position statement (2025): Liquid diet for 24 hours in all GLP-1 users. For elective cases, hold daily agents 24 hours and weekly agents 7 days. Get anesthesia involved if the hold was missed or symptoms suggest delayed emptying.
  • Multi-society / ASA 2024 shared guidance: Joint decision among endoscopist, anesthesia, and prescriber. Low-risk asymptomatic patients on stable doses may continue. Higher-risk patients follow a hold.

The 2026 OCULUS randomized trial (interim, then stopped early) found clinically significant residual gastric volume in 25% who continued the agonist versus 3% who held one dose. The gap was concentrated in EGD-only patients. Patients who also had colonoscopy after a clear-liquid day had no clinically significant residual volume. That is the most useful new number on this page.

A room rule you can actually run

  1. Ask every intake patient about weekly or daily GLP-1/GIP drugs by name (semaglutide, tirzepatide, liraglutide, dulaglutide, and the rest).
  2. Put elective EGD-only patients on 24-hour clears. Holding the weekly dose is reasonable and now has RCT support.
  3. If EGD is paired with colonoscopy, the liquid prep does most of the work. Still document the drug.
  4. On entry, look in the stomach before you commit to deep sedation without a plan. If you see a solid meal, stop. Protect the airway. Do not "just lavage and proceed" in an ambulatory room without anesthesia support.
  5. Do not postpone an urgent bleed, food impaction, or cholangitis case for a 7-day hold.

Antithrombotic holds are a different checklist. See antithrombotics around elective endoscopy.

Selected references

  1. Hashash JG, et al. AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy. Clin Gastroenterol Hepatol. 2024;22:705-707.
  2. ASGE. Position statement on periendoscopic management of patients on GLP-1 receptor agonists and SGLT-2 inhibitors. Gastrointest Endosc. 2025.
  3. GLP-1RA use and residual gastric contents and aspiration in GI endoscopy: systematic review and meta-analysis. Gastrointest Endosc. 2025;101:762-771.
  4. Holding vs continuing GLP-1/GIP agonists before upper endoscopy: the OCULUS randomized clinical trial. 2026.

Last reviewed September 20, 2026. Written for clinicians running elective and urgent endoscopy lists. Local anesthesia policy may be stricter than AGA guidance; agree the rule before the patient arrives.

For your teaching file

Save this article as a PDF

Drop your email and we'll open a print-ready version you can save as a PDF — and you'll start getting our weekly GI endoscopy newsletter.

Save as PDF

GLP-1 Agonists, NPO Status, and Aspiration Risk Before Endoscopy in 2026

Enter your email — we'll open a clean print-ready version of this article. Choose Save as PDF in the print dialog to download.